GDEV Inc. Ordinary Shares (GDEV)

GDEV Inc. Ordinary Shares (GDEV) is a biotechnology company that focuses on developing and commercializing innovative, gene-based therapies for various medical conditions. The company is involved in research and development efforts aimed at advancing treatments in the fields of genetics and regenerative medicine.

Dividend Yield 0%
Payout Frequency

Dividend History

Pay Date Amount Ex-Date Record Date
March 11, 2025 $3.31 2025-03-12 2025-03-03

Dividends Summary

Company News

3 Must-Buy Gaming Stocks to Thrive on Promising Market Trends
Benzinga • Zacks • October 14, 2024

The gaming industry is benefiting from macroeconomic tailwinds, including interest rate cuts and strong demand for sports betting. Stocks like Flutter Entertainment, DoubleDown Interactive, and GDEV Inc. are expected to gain traction from this upbeat demand.

GDEV Announces an At-The-Market Offering
GlobeNewswire Inc. • N/A • September 12, 2024

GDEV Inc. has entered into a Sales Agreement with Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. to offer and sell up to 1,757,026 ordinary shares held in treasury through an at-the-market offering. The company intends to use the net proceeds for general corporate purposes.